Posted 21 May 2020
Emory University, Department of Neurology
Interested candidates please apply at https://faculty-emory.icims.com/jobs/51679/job?mobile=false&width=768&height=500&bga=true&needsRedirect=false&jan1offset=-300&jun1offset=-240.
OR email Dr Rangaraju directly at email@example.com.
The primary focus of the lab is to define the heterogeneity in neuroimmune responses in neurodegenerative and neuroinflammatory disorders with the goal of identifying and modulating novel therapeutic targets. One therapeutic focus is microglial Kv1.3 channels and another is selectively targeting the ERK pathway in microglia, in Alzheimer’s disease. The lab is also developing novel in vivo tools for cell-type-specific proteomic characterization of brain cell types using approaches involving BONCAT and TURBID. The lab is currently R01-funded and well-supported by the Emory ADRC and CND, with close collaborations with established PIs, including Allan Levey and Nicholas Seyfried.
A doctoral degree or equivalent (Ph.D., M.D., ScD., D.V.M., DDS, etc.) in an appropriate field. Excellent scientific writing ability and strong oral communication skills. The ability to work effectively and collegially with colleagues. Additional qualifications as specified by the Principal Investigator.
The candidate must have a strong foundation in neuroscience and/or immunology, experience with traditional approaches such as flow cytometry, cell sorting as well as experience with either transcriptomics and/or proteomics approaches to characterize cell populations of interest. The candidate must be highly motivated, self-driven, independent and open to learn and adapt new methods and analytic skills to research. Proficiency in R would be preferred but not essential. Proficiency in spoken and written English is expected.